. Author manuscript; available in PMC: 2016 May 1.

Published in final edited form as: Gynecol Oncol. 2015 Feb 20;137(2):203–209. doi: 10.1016/j.ygyno.2015.02.013

Table 4. Impact of use of chemotherapy in low-risk and high-risk patients and duration of chemotherapy in high-risk patients on survival.

	Overall survival	Cancer-specific survival
Use of chemotherapy in low-risk patients	0.93 (0.65-1.33)	1.62 (0.74-3.56)
Use of chemotherapy in high-risk patients	0.70 (0.53-0.91)^*	0.89 (0.59-1.35)
Long versus short duration chemotherapy in high-risk patients	0.93 (0.67-1.27)	0.93 (0.61-1.42)

Hazard ratio (95% confidence interval).

P<0.05

Adjusted for age, race, year of diagnosis, marital status, area of residence, SEER registry, SES, comorbidity, lymphadenectomy, histology, grade, and stage.